Ciencias de la vida y de la materia Oncología personalizada de precisión

Patrick Tan: "Alteraciones epigenómicas en cánceres endémicos en Asia"

21/03/2019

Descripción
Prof. Patrick Tan is a Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology and Research). He directs PRISM, the SingHealth Duke-NUS Institute of Precision Medicine, and was Program Director of POLARIS, which established the first CAP-certified facilities for next-generation sequencing and the first clinically implemented NGS panel in South East Asia, which to date has been been applied to >1000 cancer patients. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), SingHealth Investigator Excellence Award, Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. In 2018, he received the American Association for Cancer Research (AACR) Team Science Award as Team Leader, representing the first time a team from Asia has received the award. He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a Board Member of the International Gastric Cancer Association, and co-chair of the Singapore National Precision Medicine Program Steering Committee.
"La Fundación Ramón Areces no se hace responsable de las opiniones, comentarios o manifestaciones realizados por las personas que participan en sus actividades."

Descripción

Prof. Patrick Tan is a Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology and Research). He directs PRISM, the SingHealth Duke-NUS Institute of Precision Medicine, and was Program Director of POLARIS, which established the first CAP-certified facilities for next-generation sequencing and the first clinically implemented NGS panel in South East Asia, which to date has been been applied to >1000 cancer patients. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), SingHealth Investigator Excellence Award, Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. In 2018, he received the American Association for Cancer Research (AACR) Team Science Award as Team Leader, representing the first time a team from Asia has received the award. He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a Board Member of the International Gastric Cancer Association, and co-chair of the Singapore National Precision Medicine Program Steering Committee.

"La Fundación Ramón Areces no se hace responsable de las opiniones, comentarios o manifestaciones realizados por las personas que participan en sus actividades."

Vídeos
Ciencias de la vida y de la materia Oncología personalizada de precisión

Eduardo Díaz Rubio: "Lección Magistral: Estrategias de tratamiento en oncología: una perspectiva histórica"

21/03/2019

02carlosarteaga.mp4

Rafael Rosell: "Nuevas dianas terapéuticas en cáncer de pulmón"

21/03/2019

Patrick Tan: "Alteraciones epigenómicas en cánceres endémicos en Asia"

21/03/2019

Manuel Hidalgo: "Nuevos abordajes terapéuticos en cáncer de páncreas"

21/03/2019

Florian Markowetz: "Procesos mutacionales que modulan el número de copias de los genomas del cáncer"

21/03/2019

Santiago Ramón y Cajal: "Heterogeneidad intratumoral: cómo identificarla"

21/03/2019

Pier Paolo Pandolfi: "Reactivación de supresores tumorales en la prevención y terapia del cáncer"

21/03/2019

Enzo Medico: "Oncogenómica y modelos preclínicos derivados del paciente para la medicina de precisión del cáncer colorrectal"

21/03/2019

Ignacio Melero: "La búsqueda de eficacia y de biomarcadores en inmuno-oncología"

21/03/2019

Eric Aboagye: "Imagen molecular y radiómica en la investigación del cáncer: aplicaciones a la oncología de precisión"

21/03/2019

Felipe Calvo: "Radioterapia en la oncología de precisión"

21/03/2019

José Martínez Olmos: "La oncología personalizada de precisión en el Sistema Nacional de Salud"

21/03/2019

Fernando Bandrés: "Consideraciones éticas y legales en la medicina de precisión"

21/03/2019

Paul Workman: "Futuro y sostenibilidad de la investigación en oncología de precisión"

21/03/2019